Author

James Blackburn

Queen Mary University of LondonPrimary ORCID profile (0000-0001-5216-8815 · 6 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

James BlackburniD6 papers · Garvan Institute of Medical Research

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Angelica Gualtieri· 1 shared Ashutosh RaiiD· 1 shared Carles Gaston‐MassuetiD· 1 shared Charlotte Louise HalliD· 1 shared Federico RoncaroliiD· 1 shared James NicholsoniD· 1 shared Jingyi XueiD· 1 shared Kalyana C. Gangaraju· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angelica Gualtieri

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Disruption of the Wnt-antagonist Apc in the pituitary stem cells drives the development of adamantinomatous craniopharyngioma.

James Blackburn, Laura Gomez-Corral, James Nicholson, Ashutosh Rai, Jingyi Xue, Rachael Tan, Kalyana C. Gangaraju, Angelica Gualtieri, Charlotte Louise Hall, Pinaki R Dutta, Márta Korbonits, Federico Roncaroli, Shannon William Davis, Carles Gaston‐Massuet

This study shows that disrupting Apc in pituitary stem cells causes adamantinomatous craniopharyngioma (aCP) in mice, independent of β-catenin mutations, and identifies Sox2+ stem cells as the cell of origin.

bioRxiv · Sep 28, 2025 · PreprintCancer Biology